Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?
Women who are eligible to participate in the study include:
Women who are not eligible:
Quality of Life:
Breast Cancer Survivor
High Risk But No Cancer
Ovarian Cancer Survivor
The study is being conducted by researchers at the University of Pennsylvania. Contact Stephanie Criniti, Research Coordinator by phone at (215) 573-9695 or by email.
Dr. C. Neill Epperson and her research team at the Penn Center for Women's Behavioral Wellness are studying the effects of a stimulant medication called Vyvanse® on memory and attention in women who had surgery to remove their ovaries to lower their risk for ovarian cancer (risk-reducing salpingo-oophorectomy or RRSO).
Read our blog that includes an interview with a study participant.
This is a 2-arm, double-blind, randomized, placebo controled, cross-over study.
Participants who meet initial criteria and enroll will follow this schedule:
Participants will be compensated for their time participating in the study. Total compensation is up to $650.
Four out of seven visits can be completed remotely. The remaining three visits are MRI sessions that must be completed at the University of Pennsylvania.
Neill Epperson, MD: email@example.com
Susan Domchek, MD.